People · Operator
Named in public records as an officer, director or promoter · active 2015–2015 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Lyric Pharmaceuticals Inc. | — | Pharmaceuticals | Series B | $26.8M | $910.8M | 2015 |
David Wurtman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Wurtman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kevin Lalande | 1 | 8 |
| Niall O'Donnell | 1 | 7 |
| Casey Cunningham | 1 | 7 |
| Jason Hong | 1 | 4 |
| Sanford Zweifach | 1 | 1 |
| M. Scott Harris | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.